Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Fig. 4

Representative immunohistochemistry images for patients with tumor/stromal Cav-1 staining. a Tumor exhibited strong intensity (3), moderate intensity (2), weak intensity (1) and negative (0) for Cav-1 (from right panel to left panel). b Stromal exhibited strong intensity (3), moderate intensity (2), weak intensity (1) and negative (0) for Cav-1 (from right panel to left panel). Abbreviations: Cav-1, Caveolin-1

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us